1xbet 로그인., Ltd.
Pharmaceuticals
November 1, 2017
1xbet 로그인 will Initiate a Third Phase 3 Trial to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Dementia of the Alzheimer's Type
1xbet 로그인., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announce that the two companies will initiate a third clinical phase 3 study for brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimer's type. The trial is expected to commence during the first half of 2018.
The decision to initiate a third trial follows discussions with the U.S. Food and Drug Administration (FDA) regarding two phase 3 clinical trials for the agitation indication that were completed by 1xbet 로그인 earlier this year. Top-line results for the two completed trials were announced in May 2017.
Latest Pharmaceutical Business related News Rele1xbet 로그인es